Halozyme Just Bought Its Next Decade Of Growth

Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been around six months since my previous Halozyme (NASDAQ: HALO ) article , where I defended the company’s growth designation thanks to an impressive Q1 earnings with a 35% increase in revenue, 54% net income growth, and management raising theirHe ...